Evidence map›Paper›PMID 34590864›Full record

ArticleJournal of the American Chemical Society2021

Late-Stage

Yangyang Shen, Tomislav Rovis

Abstract read
In one paragraph

Article in Journal of the American Chemical Society, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed.

  1. Direct enantioselective C(spNature chemistry · 2026
    Article
  2. Article
  3. Article
  4. Article
  5. Journal of the American Chemical Society · 2025
    Article
  6. Ir/Ni Metallaphotoredox Catalysis for the C(spChemistry (Weinheim an der Bergstrasse, Germany) · 2025
    Article
  7. Article
  8. Article
  9. Photoredox-catalyzed C(Science advances · 2024
    Article
  10. Review
  11. Photoinduced Nickel-Catalyzed SelectiveJournal of the American Chemical Society · 2023
    Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Yangyang ShenDepartment of Chemistry, Columbia University, New York, New York 10027, United States.ORCID 0000-0003-4607-9722
Tomislav RovisDepartment of Chemistry, Columbia University, New York, New York 10027, United States.ORCID 0000-0001-6287-8669

Funding

Selective Functionalization of Aliphatic Amines - Supplement to Support Mariah RamosR01GM125206 · NIGMS · COLUMBIA UNIV NEW YORK MORNINGSIDE · PI ROVIS, TOMISLAV · 2017 to 2024
$2.6M
NIGMS NIH HHS R01 GM125206
6 · The paper itself

Abstract

The diversity and wide availability of trialkylamines render them ideal sources for rapid construction of complex amine architectures. Herein, we report that a nickel/photoredox dual catalysis strategy affects site-selective α-arylation of various trialkylamines. Our catalytic system shows exclusive

Indexed as

AminesNickelOxidation-ReductionPhotochemical ProcessesCatalysisMolecular StructureAminesNickel

Identifiers

PMID34590864
PMCPMC8862118

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.